spacer
home > pmps > winter 2003 > the ultimate solution for reducing medication errors
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

The Ultimate Solution for Reducing Medication Errors

Are the right patients receiving the right drugs in the right dosage at the right time? Preventing medication errors is high on the agenda not only of hospitals, but the pharmaceutical wholesalers, the pharmaceutical industry and also governments worldwide. The American health care sector is focusing on minimising errors in administering medication. By scanning medication at the patient's bedside, errors can be reduced by as much as 50 per cent or more according to the Federal Drug Administration (FDA). It is no wonder therefore that in mid-2003, the FDA ruled that there should be bar codes on each unit dose. Much research is carried out in order to calculate the percentage of medication errors occurring. Just about every country worldwide has done at least one research project on this subject.

Depending on which research report you read (and depending on the definition of medication error used) the percentage of medication errors varies between 10 and 25 per cent. Almost 0.5 per cent result in permanent injury and 0.25 per cent of patients die due to the wrong medicine or wrong dosage being administered. Although it looks like a small percentage in relation to the size of the population, this number is unacceptable. In addition, the costs of recovery, such as the expense of contra-medication and an extra stay in hospital, are estimated to be an annual ˆ300 million in countries such as The Netherlands. These figures are worrying, especially if you have ever been a patient, and solutions must be found.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Eric Tjoa, CEO at Tjoapack BV

Eric Tjoa founded TjoaPack, a pharmaceutical contract packaging company, in 1989. He holds a Masters in Pharmacy and has given several national and international presentations concerning bar coding and standardisation of unit dose packages, amongst other subjects, at the University of the Western Cape, the EAN conferences in 2002 and 2003, and at the EAHP 1999 in Nice.

spacer
Eric Tjoa
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Molekule Consulting Inc Today Announces its Exhibiting at the 2015 Pharma Competitive Intelligence Conference and Exhibition USA

At the Pharma CI USA Conference, Mr. Alderman will present a talk entitled, “CI=ROI. Emerging Markets in biopharmaceuticals – how leveraging primary competitive intelligence returns robust ROIs in key global growth driver markets” where he will discuss emerging markets as targets and subjects of competitive intelligence research.
More info >>

White Papers

Quality By Design

Biopharma Group

Quality by Design (QbD) is a systematic approach to development that begins with the defined objectives and emphasizes science and quality risk management in order to achieve those goals. QbD ensures that the quality of the product is built into production processes from the outset, rather than being tested after development has already commenced.
More info >>

 
Industry Events

MAGHREB PHARMA Expo

29 September - 1 October 2015, Hilton Hotel, Algiers (Algeria)

MAGHREB PHARMA Expo is the largest pharmaceutical technology tradeshow in Africa
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement